AnalystsInsight

Brian Meredith (UBS): Analyst Track Record and Price‑Target Accuracy

How often Brian Meredith’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,279 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Brian Meredith ranks #71 of 1,181 analysts in Exent’s scoring (5.0★).
  • 45.2% of price targets were reached over 7 years, versus 53.1% for the average analyst.
  • Median time to reach a target: 137 days; 70.6% of calls were up 12 months later.
  • Most‑covered stocks: PGR, BRK.B, GSHD, AJG.
  • Free on Exent: Brian Meredith’s full record, with ratings 3 days after publication.

Which stocks do Wall Street’s best‑ranked analysts agree on? See them in Exent Gems →

Brian Meredith’s track record at a glance

Brian Meredith of UBS ranks #71 of the 1,181 analysts Exent scores, with a 5.0★ rating and a focus on financials. Over a 7‑year lookback, 45.2% of Brian’s price targets were reached, 7.9 points below the 53.1% average across all analysts.

MetricBrian MeredithAll analysts
Price‑target hit rate45.2%53.1%
Median days to hit target137 days93 days
Calls up after 12 months70.6%64.4%
Median 12‑month return of calls+11.0%+13.5%
Hit rate, last 2 years35.2%—
Average worst drop after a call−13.4%—
Ratings in the sample1,279—
Stocks covered39—

The full records of Exent’s top 50 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetBrian Meredith
Under 30 days12.5%
30–90 days20.4%
90–180 days27.6%
Over 180 days39.5%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Brian Meredith covers most

StockRatings in the sample
PGR30
BRK.B26
GSHD22
AJG21
RYAN21
WRB20
HIG20
RNR19

In the past year Brian’s ratings were 59% Buy, 41% Hold and 0% Sell.

Exent’s top 50 analysts

Across 983,543 ratings, the average Wall Street analyst’s price target was reached 53.1% of the time: close to a coin flip. The spread between analysts is wide, and 14.3% of the 965 analysts with a measurable record reached 70% or more (Exent data, Nov 9, 2026).

Exent Gems is built on the top 50 of Exent’s ranking. Over the last two years, some of them reached 90% or more of their price targets. Who they are, which stocks they are calling now and how often they have been right is for members.

Brian Meredith’s latest ratings

DateStockActionRatingPrice target
Nov 10, 2026????????????
Nov 2, 2026AJGMaintained: BuyBuy$320.00
Nov 2, 2026BROReiterated: HoldHold$72.00
Nov 2, 2026RNRMaintained: HoldHold$366.00
Nov 2, 2026RYANMaintained: BuyBuy$52.00
Nov 2, 2026ACGLReiterated: BuyBuy$125.00
Nov 2, 2026AONReiterated: HoldHold$356.00
Nov 2, 2026EGReiterated: HoldHold$423.00
Nov 2, 2026WTWReiterated: BuyBuy$395.00
  • Nov 10, 2026
    Stock
    ???
    Action
    ???
    Rating
    ???
    Price target
    ???
  • Nov 2, 2026
    Stock
    AJG
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $320.00
  • Nov 2, 2026
    Stock
    BRO
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $72.00
  • Nov 2, 2026
    Stock
    RNR
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $366.00
  • Nov 2, 2026
    Stock
    RYAN
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $52.00
  • Nov 2, 2026
    Stock
    ACGL
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $125.00
  • Nov 2, 2026
    Stock
    AON
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $356.00
  • Nov 2, 2026
    Stock
    EG
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $423.00
  • Nov 2, 2026
    Stock
    WTW
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $395.00

Brian published 1 rating in the last 3 days, the latest on Nov 10, 2026. Brian’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

More analysts to compare

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Nov 9, 2026; ranking updated Nov 11, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows live ratings from the top‑ranked analysts, without the 3‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Brian Meredith ranks #71 of 1,181 with a 5.0★ rating. 45.2% of price targets were reached over a 7-year lookback (all analysts: 53.1%), and 70.6% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

In Exent’s 7-year price-target backtest, 45.2% of Brian Meredith’s price targets were reached, with a median of 137 days to reach a target (all analysts: 53.1%).

Brian Meredith (UBS) covers 39 stocks, mostly in financials. The most frequently rated are PGR, BRK.B, GSHD, AJG, RYAN.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.